glp-1 competitive landscape Obesity Market What is Competitive Landscape of

GLP-1 recepter agonist 1

Schedule your consultation today!

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), such as semaglutide, are widely used in the treatment of metabolic disorders, including type 2 diabetes (T2D) and obesity

Supports GLP-1 naturally* Formulated with: Akkermansia muciniphila generates the postbiotics propionate and p9 which supports GLP-1 production* Clostridium butyricum produces the postbiotic butyrate which stimulates GLP-1. Bifidobacterium infantis produces the postbiotics acetate and lactate which feed bacteria such as Akkermansia and Butyricum, promoting an ecosystem in the gut that supports a healthy gut lining and GLP-1 naturally

GLP-1 agonists are pivotal in obesity care, promoting weight loss and addressing related health issues, with a focus on personalized, holistic treatment.